American Express has started offering digital memorabilia to customers in the form of non-fungible token stamps issued on the Base blockchain. As of Sep. 16, American Express has officially unveiled the Amex Passport initiative, via which the payments giant will…American Express has started offering digital memorabilia to customers in the form of non-fungible token stamps issued on the Base blockchain. As of Sep. 16, American Express has officially unveiled the Amex Passport initiative, via which the payments giant will…

American Express starts offering NFT travel stamps to customers as memorabilia

2025/09/16 14:35
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

American Express has started offering digital memorabilia to customers in the form of non-fungible token stamps issued on the Base blockchain.

Summary
  • American Express is issuing NFT travel stamps on the Ethereum Layer-2 Base for U.S. cardholders.
  • The NFT stamps cannot be transferred or sold on the open market.
  • Stamps are ERC-721 tokens that show the country or region visited, description, and date, without storing personal data.

As of Sep. 16, American Express has officially unveiled the Amex Passport initiative, via which the payments giant will issue NFT travel stamps for customers who hold the US Amex consumer card and link it to their online account. 

Every stamp is an ERC-721 token that is issued on the Ethereum layer-2 Base, and has been designed to capture a traveler’s journey by showing the country or region visited, along with a short description and the date it was earned. No personal information or details of the trip would be recorded on the blockchain.

However, unlike most commercially available NFTs, Amex stamps have no monetary value and cannot be traded on the open market. It is only accessible via the Amex Passport section on the official Amex Travel App and won’t incur any additional charges.

“As physical passport stamps continue to disappear, Amex Passport creates an opportunity for Card Members to celebrate their travels,” said Luke Gebb, Executive Vice President at Amex Digital Labs, the subsidiary that developed the initiative.

According to the company’s website, stamps would be automatically visible in the Amex Passport section after a customer makes an “in-person purchase,” during their travels, to any of the 130 qualifying countries and regions using either the physical Card or a digital wallet like Apple Pay or Google Pay.

Data from Base Explorer shows that the Amex travel stamp smart contract was created 25 days ago, and over 20,000 NFTs have been issued to date.

NFTs and tourism

Over the past years, NFTs have moved beyond being just speculative assets, evolving into collectible digital rewards that offer an immutable way to mark experiences, build loyalty, and give travelers a lasting record of their journeys, among many other use cases.

Back in 2023, German aviation company Lufthansa Group started offering passengers NFTs issued on the Polygon blockchain as rewards. More recently, the Indian Railway Catering and Tourism Corporation has issued NFT tickets on multiple occasions for certain special trains.

Earlier this year, South Korea’s Jeju Island was mulling the launch of an NFT-based digital tourism resident card sometime in the second half of 2025, which would offer exclusive benefits such as travel subsidies, membership perks, and discounts at local attractions.

American Express and Coinbase launch Bitcoin card

For American Express, this is not the first time it has worked closely with a crypto-native firm. The launch of Amex Passports comes just months after Coinbase unveiled the Coinbase One Card in partnership with American Express.

The card is slated for release this fall and will offer Bitcoin as a cashback reward for transactions, starting at 2% and scaling up to 4% depending on the user’s asset holdings on Coinbase.

Market Opportunity
FORM Logo
FORM Price(FORM)
$0.2805
$0.2805$0.2805
-0.14%
USD
FORM (FORM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09